Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Marinus Pharmaceuticals Company Profile (NASDAQ:MRNS)

Consensus Ratings for Marinus Pharmaceuticals (NASDAQ:MRNS) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.25 (77.46% upside)

Analysts' Ratings History for Marinus Pharmaceuticals (NASDAQ:MRNS)
Show:
DateFirmActionRatingPrice TargetActions
5/19/2015Janney Montgomery ScottReiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/16/2015OppenheimerReiterated RatingOutperform$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/9/2014OppenheimerInitiated CoverageOutperform$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/26/2014JMP SecuritiesInitiated CoverageOutperform$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Stifel NicolausInitiated CoverageBuy$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2014Janney Montgomery ScottInitiated CoverageBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/27/2013 forward)